BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19604266)

  • 1. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis.
    Harada K; Shimoda S; Sato Y; Isse K; Ikeda H; Nakanuma Y
    Clin Exp Immunol; 2009 Aug; 157(2):261-70. PubMed ID: 19604266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary innate immunity in the pathogenesis of biliary diseases.
    Harada K; Nakanuma Y
    Inflamm Allergy Drug Targets; 2010 Jun; 9(2):83-90. PubMed ID: 20402650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary innate immunity: function and modulation.
    Harada K; Nakanuma Y
    Mediators Inflamm; 2010; 2010():. PubMed ID: 20798866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of biliary tract injury in primary biliary cirrhosis].
    Ishibashi H; Shimoda S
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):455-62. PubMed ID: 23291480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells.
    Shimoda S; Harada K; Niiro H; Yoshizumi T; Soejima Y; Taketomi A; Maehara Y; Tsuneyama K; Nakamura M; Komori A; Migita K; Nakanuma Y; Ishibashi H; Selmi C; Gershwin ME
    Hepatology; 2008 Mar; 47(3):958-65. PubMed ID: 18181218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia.
    Okamura A; Harada K; Nio M; Nakanuma Y
    Clin Exp Immunol; 2013 Aug; 173(2):268-75. PubMed ID: 23607494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.
    Harada K; Isse K; Nakanuma Y
    J Clin Pathol; 2006 Feb; 59(2):184-90. PubMed ID: 16443736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of oestrogen-related receptor γ on biliary epithelial cells in the pathogenesis of primary biliary cirrhosis.
    Harada K; Yuko K; Sato Y; Ikeda H; Nakanuma Y
    J Clin Pathol; 2014 Jul; 67(7):566-72. PubMed ID: 24687322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally-occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis.
    Sasaki M; Ikeda H; Sawada S; Sato Y; Nakanuma Y
    J Clin Pathol; 2007 Oct; 60(10):1102-7. PubMed ID: 17158635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-chemokine receptor CCL2-CCR2 and CX3CL1-CX3CR1 axis may play a role in the aggravated inflammation in primary biliary cirrhosis.
    Sasaki M; Miyakoshi M; Sato Y; Nakanuma Y
    Dig Dis Sci; 2014 Feb; 59(2):358-64. PubMed ID: 24185682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in the pathogenesis of cholangiopathy: a recent update.
    Harada K; Nakanuma Y
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):478-83. PubMed ID: 22920631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis.
    Huang Q; Chu S; Yin X; Yu X; Kang C; Li X; Qiu Y
    Tohoku J Exp Med; 2016 Dec; 240(4):269-275. PubMed ID: 27916760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.
    Harada K; Isse K; Kamihira T; Shimoda S; Nakanuma Y
    Hepatology; 2005 Jun; 41(6):1329-38. PubMed ID: 15880426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis.
    Ronca V; Mancuso C; Milani C; Carbone M; Oo YH; Invernizzi P
    J Leukoc Biol; 2020 Aug; 108(2):659-671. PubMed ID: 32349179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential cytokine pathways for therapeutic intervention in murine primary biliary cirrhosis.
    Kawata K; Tsuda M; Yang GX; Zhang W; Tanaka H; Tsuneyama K; Leung P; He XS; Knechtle S; Ansari AA; Coppel RL; Gershwin ME
    PLoS One; 2013; 8(9):e74225. PubMed ID: 24040208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
    Kawata K; Kobayashi Y; Gershwin ME; Bowlus CL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic IL-17 responses in human and murine primary biliary cirrhosis.
    Lan RY; Salunga TL; Tsuneyama K; Lian ZX; Yang GX; Hsu W; Moritoki Y; Ansari AA; Kemper C; Price J; Atkinson JP; Coppel RL; Gershwin ME
    J Autoimmun; 2009 Feb; 32(1):43-51. PubMed ID: 19101114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary innate immunity and cholangiopathy.
    Harada K; Nakanuma Y
    Hepatol Res; 2007 Oct; 37 Suppl 3():S430-7. PubMed ID: 17931198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
    Yang CY; Ma X; Tsuneyama K; Huang S; Takahashi T; Chalasani NP; Bowlus CL; Yang GX; Leung PS; Ansari AA; Wu L; Coppel RL; Gershwin ME
    Hepatology; 2014 May; 59(5):1944-53. PubMed ID: 24375552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population.
    Rong G; Zhou Y; Xiong Y; Zhou L; Geng H; Jiang T; Zhu Y; Lu H; Zhang S; Wang P; Zhang B; Zhong R
    Clin Exp Immunol; 2009 May; 156(2):217-25. PubMed ID: 19302244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.